LAS VEGAS and RENO, Nev., Oct. 2, 2024 /PRNewswire/ -- Ambetter from SilverSummit Healthplan, a product offered by a Centene Corporation (NYSE: CNC) company. which provides insurance to under-insured and uninsured populations through the State Based Exchange, will offer a variety of affordable health insurance plans in Nevada for plan year 2025. Open enrollment for the Health Insurance Marketplace® for Nevada runs from Nov. 1, 2024, through Jan. 15, 2025. Enroll by Dec. 15, 2024, for coverage starting Jan. 1, 2025.
"Nevadans can count on Ambetter from SilverSummit Healthplan. As the only health plan offered in all 17 Nevada counties since 2017, Ambetter's large provider network offers access to primary care and specialists to support your healthcare needs, wherever you may live in our great state," said SilverSummit Healthplan President and Chief Executive Officer Eric Schmacker.
Ambetter from SilverSummit Healthplan offers its members access to quality care, convenient services and valuable rewards. 2025 benefits and offerings include:
Nevada residents interested in learning more about Ambetter from SilverSummit Healthplan or enrolling in a health plan during the open enrollment period may visit Ambetter.SilverSummitHealthplan.com.
About Ambetter from SilverSummit Healthplan
Ambetter from SilverSummit Healthplan serves under-insured and uninsured populations through the Nevada State Based Exchange, Nevada Health Link. Ambetter from SilverSummit Healthplan is underwritten by SilverSummit Healthplan, Inc., which is a Qualified Health Plan issuer in Nevada. For more information, visit ambetterhealth.com/en/nv. This is a solicitation for insurance. For information on your right to receive an Ambetter from SilverSummit Healthplan free of discrimination, or your right to receive language, auditory and/or visual assistance services, please visit ambetterhealth.com/en/ and scroll to the bottom of the page.
Last Trade: | US$59.10 |
Daily Change: | 1.29 2.23 |
Daily Volume: | 4,074,504 |
Market Cap: | US$29.840B |
October 30, 2024 October 25, 2024 September 11, 2024 August 29, 2024 |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB